MedWatch

Pfizer gives Danish PM cold shoulder: rejects idea of starting vaccine production in Denmark

Although three of the world's largest pharmaceutical companies have expressed interest in establishing vaccine production facilities in Denmark, Pfizer is not interested in working with the Danish authorities.

Photo: Pool/Reuters/Ritzau Scanpix

Although the Pfizer/Biontech vaccine is the most widely used covid-19 vaccine in Denmark, it does not look like the companies will be establishing vaccine production facilities in the country.

That ship has sailed, as Pfizer has already expanded its production across the world, and now, it has upped its goal of producing 1.3 billion doses in 2021 to more than 2.5 billion doses. From next year onwards, more than 3 billion doses will be produced.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Orphazyme cuts guidance following FDA setback

Friday's disappointing rejection letter from the US FDA is affecting Orphazyme's guidance for 2021. Now, the biotech firm forecasts an operating deficit of DKK 670-700m, up from DKK 100-150m.

Further reading

Related articles

Latest news

See all jobs